Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
4.220
-0.100 (-2.31%)
At close: Dec 5, 2025, 4:00 PM EST
4.241
+0.021 (0.51%)
After-hours: Dec 5, 2025, 7:24 PM EST
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $262.75 million as of December 5, 2025. Its market cap has increased by 8.03% in one year.
Market Cap
262.75M
Enterprise Value
205.57M
1-Year Change
8.03%
Ranking
Category
Stock Price
$4.22
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $262.75M, a decrease of -49.83%. That is a compound annual growth rate of -15.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 268.98M | 189.96% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |